Glenmark Pharma To Raise Up To USD 200 Million To Refinance Debt

Glenmark Pharmaceuticals Ltd. plans to raise up to USD 200 million through dollar-denominated bonds to refinance debt. Proceeds from the bond sale will be used to refinance existing debt raised through dollar bonds in 2016. The earlier dollar notes, priced at 4.5 percent coupon rate, have a bi-annual payment schedule, and mature in 2021.

Share this:

Related Post

Stay Updated on Medical Equipment and Devices industry.
Receive our Daily Newsletter.